These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 29941991)

  • 1. Phytate Decreases Formation of Advanced Glycation End-Products in Patients with Type II Diabetes: Randomized Crossover Trial.
    Sanchis P; Rivera R; Berga F; Fortuny R; Adrover M; Costa-Bauza A; Grases F; Masmiquel L
    Sci Rep; 2018 Jun; 8(1):9619. PubMed ID: 29941991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Daily phytate intake increases adiponectin levels among patients with diabetes type 2: a randomized crossover trial.
    Sanchis P; Calvo P; Pujol A; Rivera R; Berga F; Fortuny R; Costa-Bauza A; Grases F; Masmiquel L
    Nutr Diabetes; 2023 Feb; 13(1):2. PubMed ID: 36854678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of n-3 long-chain polyunsaturated fatty acid supplementation on AGEs and sRAGE in type 2 diabetes mellitus.
    Kurt A; Andican G; Siva ZO; Andican A; Burcak G
    J Physiol Biochem; 2016 Dec; 72(4):679-687. PubMed ID: 27448155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of dietary prebiotic supplementation on advanced glycation, insulin resistance and inflammatory biomarkers in adults with pre-diabetes: a study protocol for a double-blind placebo-controlled randomised crossover clinical trial.
    Kellow NJ; Coughlan MT; Savige GS; Reid CM
    BMC Endocr Disord; 2014 Jul; 14():55. PubMed ID: 25011647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. l-Carnosine supplementation attenuated fasting glucose, triglycerides, advanced glycation end products, and tumor necrosis factor-α levels in patients with type 2 diabetes: a double-blind placebo-controlled randomized clinical trial.
    Houjeghani S; Kheirouri S; Faraji E; Jafarabadi MA
    Nutr Res; 2018 Jan; 49():96-106. PubMed ID: 29420997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Effects of Taurine Supplementation on Metabolic Profiles, Pentosidine, Soluble Receptor of Advanced Glycation End Products and Methylglyoxal in Adults With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Esmaeili F; Maleki V; Kheirouri S; Alizadeh M
    Can J Diabetes; 2021 Feb; 45(1):39-46. PubMed ID: 32861603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of adjunctive photodynamic therapy on the clinical periodontal, HbA1c and advanced glycation end product levels among mild to moderate chronic periodontal disease patients with type 2 diabetes mellitus: A randomized controlled clinical trial.
    Mirza S; Khan AA; Al-Kheraif AA; Khan SZ; Shafqat SS
    Photodiagnosis Photodyn Ther; 2019 Dec; 28():177-182. PubMed ID: 31394300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced glycation end products (AGEs) and their soluble receptors (sRAGE) as early predictors of reno-vascular complications in patients with uncontrolled type 2 diabetes mellitus.
    Farhan SS; Hussain SA
    Diabetes Metab Syndr; 2019; 13(4):2457-2461. PubMed ID: 31405660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of low- and high-advanced glycation endproduct meals on macro- and microvascular endothelial function and oxidative stress in patients with type 2 diabetes mellitus.
    Negrean M; Stirban A; Stratmann B; Gawlowski T; Horstmann T; Götting C; Kleesiek K; Mueller-Roesel M; Koschinsky T; Uribarri J; Vlassara H; Tschoepe D
    Am J Clin Nutr; 2007 May; 85(5):1236-43. PubMed ID: 17490958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of sevelamer carbonate on advanced glycation end products and antioxidant/pro-oxidant status in patients with diabetic kidney disease.
    Yubero-Serrano EM; Woodward M; Poretsky L; Vlassara H; Striker GE;
    Clin J Am Soc Nephrol; 2015 May; 10(5):759-66. PubMed ID: 25710801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Action of metformin therapy against advanced glycation, oxidative stress and inflammation in type 2 diabetes patients: 3 months follow-up study.
    Adeshara KA; Bangar NS; Doshi PR; Diwan A; Tupe RS
    Diabetes Metab Syndr; 2020; 14(5):1449-1458. PubMed ID: 32769032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New Frontiers for the Use of IP6 and Inositol Combination in Treating Diabetes Mellitus: A Review.
    Omoruyi FO; Stennett D; Foster S; Dilworth L
    Molecules; 2020 Apr; 25(7):. PubMed ID: 32290029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired osteogenic differentiation and enhanced cellular receptor of advanced glycation end products sensitivity in patients with type 2 diabetes.
    Phimphilai M; Pothacharoen P; Kongtawelert P; Chattipakorn N
    J Bone Miner Metab; 2017 Nov; 35(6):631-641. PubMed ID: 27873077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between Fluorescent Advanced Glycation End-Products and Vascular Complications in Type 2 Diabetic Patients.
    Guerin-Dubourg A; Cournot M; Planesse C; Debussche X; Meilhac O; Rondeau P; Bourdon E
    Biomed Res Int; 2017; 2017():7989180. PubMed ID: 29362717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Inositol Hexaphosphate (IP
    Ikenaga T; Kakumoto K; Kohda N; Yamamoto T
    Plant Foods Hum Nutr; 2019 Sep; 74(3):316-321. PubMed ID: 31119466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding the Protective Effect of Phytate in Bone Decalcification Related-Diseases.
    Sanchis P; López-González ÁA; Costa-Bauzá A; Busquets-Cortés C; Riutord P; Calvo P; Grases F
    Nutrients; 2021 Aug; 13(8):. PubMed ID: 34445019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of glycemic control on advanced glycation and inflammation in overweight and obese patients with type 2 diabetes mellitus.
    Kalninova J; Jakus V; Glejtkova M; Kuracka L; Sandorova E
    Bratisl Lek Listy; 2014; 115(8):457-68. PubMed ID: 25246279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro (α-glucosidase and α-amylase inhibition) and in vivo antidiabetic property of phytic acid (IP6) in streptozotocin- nicotinamide-induced type 2 diabetes mellitus (NIDDM) in rats.
    Kuppusamy A; Muthusamy U; Thirumalaisamy SA; Varadharajan S; Ramasamy K; Ramanathan S
    J Complement Integr Med; 2011 Jan; 8():. PubMed ID: 22754949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carnosine decreased oxidation and glycation products in serum and liver of high-fat diet and low-dose streptozotocin-induced diabetic rats.
    Aydın AF; Bingül İ; Küçükgergin C; Doğan-Ekici I; Doğru Abbasoğlu S; Uysal M
    Int J Exp Pathol; 2017 Oct; 98(5):278-288. PubMed ID: 29205589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skin autofluorescence is associated with severity of vascular complications in Japanese patients with Type 2 diabetes.
    Tanaka K; Tani Y; Asai J; Nemoto F; Kusano Y; Suzuki H; Hayashi Y; Asahi K; Nakayama M; Miyata T; Watanabe T
    Diabet Med; 2012 Apr; 29(4):492-500. PubMed ID: 21916970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.